schliessen

Filtern

 

Bibliotheken

First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran

Factor XIII deficiency (FXIIID) is an extremely rare bleeding disorder with the highest global incidence in southeast of Iran. Southwestern Afghanistan (Nimruz Province) is located near the border with Iran in the vicinity of Sistan and Baluchestan Province in southeast Iran, and there seems to be a... Full description

Journal Title: Blood Coagulation & Fibrinolysis 2015, Vol.26(8), pp.908-911
Main Author: Hosseini, Soudabeh
Other Authors: Dorgalaleh, Akbar , Bamedi, Taregh , Tavakol, Khanagha , Tabibian, Shadi , Naderi, Majid , Alizadeh, Shaban , Varmaghani, Bijan , Shamsizadeh, Morteza , Rahimizadeh, Aziz , Ebrahimi, Sharif
Format: Electronic Article Electronic Article
Language:
Subjects:
ID: ISSN: 0957-5235 ; DOI: 10.1097/MBC.0000000000000358
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: ovid10.1097/MBC.0000000000000358
title: First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran
format: Article
creator:
  • Hosseini, Soudabeh
  • Dorgalaleh, Akbar
  • Bamedi, Taregh
  • Tavakol, Khanagha
  • Tabibian, Shadi
  • Naderi, Majid
  • Alizadeh, Shaban
  • Varmaghani, Bijan
  • Shamsizadeh, Morteza
  • Rahimizadeh, Aziz
  • Ebrahimi, Sharif
subjects:
  • Epistaxis -- Genetics
  • Factor XIII -- Genetics
  • Factor XIII Deficiency -- Genetics
  • Genetic Diseases, Inborn -- Genetics
  • Hematoma -- Genetics
  • Hematuria -- Genetics
ispartof: Blood Coagulation & Fibrinolysis, 2015, Vol.26(8), pp.908-911
description: Factor XIII deficiency (FXIIID) is an extremely rare bleeding disorder with the highest global incidence in southeast of Iran. Southwestern Afghanistan (Nimruz Province) is located near the border with Iran in the vicinity of Sistan and Baluchestan Province in southeast Iran, and there seems to be a high prevalence of FXIIID in Nimruz. Thus, this cross-sectional study was designed to assess the prevalence of FXIIID, molecular basis as well as clinical manifestations of FXIIID in Southwestern Afghanistan. During the course of the study, all patients suspected of FXIIID were clinically examined and assessed by routine coagulation tests, including bleeding time, activated partial thromboplastin time, prothrombin time, as well as platelet count and clot solubility test. Patients with normal routine coagulation tests, but abnormal clot solubility test, underwent further investigations by FXIII activity, as well as molecular analysis for FXIII-A gene mutation (Trp187Arg) by PCR-restriction fragment length polymorphism that confirmed by sequencing. Patients with confirmed FXIIID deficiency were registered to receive prophylaxis treatment. All data including demographic information, clinical manifestations, as well as therapeutic response and type and duration of treatment, were recorded, and the data were analyzed by SPSS software. In this cross-sectional study, we found five patients with abnormal clot solubility test, among whom two patients abandoned the study, whereas three patients remained for a more precise study. All the patients were residents of Zaranj city, the capital of Nimruz Province. All these patients had undetectable activity of FXIII, which indicates a severe deficiency. Molecular analysis of patients showed mutation of Trp187Arg in all of them. Hematoma was the most common clinical presentation leading to diagnosis of FXIIID in these patients (100%). Epistaxis (67%), gum bleeding (33%), and hematuria (33%) were other recurrent clinical presentations of the patients. Three cases of death due to FXIIID were detected in the family of these patients. There was a high prevalence of FXIIID in Zaranj city with a population of 50 000, which was appropriately equal to the prevalence of the disorder in southeast of Iran, which seemed to have the highest global prevalence of FXIIID, and underlines that the same mutation (Trp187Arg) in both regions is same.
language:
source:
identifier: ISSN: 0957-5235 ; DOI: 10.1097/MBC.0000000000000358
fulltext: fulltext
issn:
  • 0957-5235
  • 09575235
url: Link


@attributes
ID1748825538
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1097/MBC.0000000000000358
sourceidovid
recordidTN_ovid10.1097/MBC.0000000000000358
sourceformatXML
sourcesystemPC
pqid1728669076
display
typearticle
titleFirst cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran
creatorHosseini, Soudabeh ; Dorgalaleh, Akbar ; Bamedi, Taregh ; Tavakol, Khanagha ; Tabibian, Shadi ; Naderi, Majid ; Alizadeh, Shaban ; Varmaghani, Bijan ; Shamsizadeh, Morteza ; Rahimizadeh, Aziz ; Ebrahimi, Sharif
ispartofBlood Coagulation & Fibrinolysis, 2015, Vol.26(8), pp.908-911
identifierISSN: 0957-5235 ; DOI: 10.1097/MBC.0000000000000358
descriptionFactor XIII deficiency (FXIIID) is an extremely rare bleeding disorder with the highest global incidence in southeast of Iran. Southwestern Afghanistan (Nimruz Province) is located near the border with Iran in the vicinity of Sistan and Baluchestan Province in southeast Iran, and there seems to be a high prevalence of FXIIID in Nimruz. Thus, this cross-sectional study was designed to assess the prevalence of FXIIID, molecular basis as well as clinical manifestations of FXIIID in Southwestern Afghanistan. During the course of the study, all patients suspected of FXIIID were clinically examined and assessed by routine coagulation tests, including bleeding time, activated partial thromboplastin time, prothrombin time, as well as platelet count and clot solubility test. Patients with normal routine coagulation tests, but abnormal clot solubility test, underwent further investigations by FXIII activity, as well as molecular analysis for FXIII-A gene mutation (Trp187Arg) by PCR-restriction fragment length polymorphism that confirmed by sequencing. Patients with confirmed FXIIID deficiency were registered to receive prophylaxis treatment. All data including demographic information, clinical manifestations, as well as therapeutic response and type and duration of treatment, were recorded, and the data were analyzed by SPSS software. In this cross-sectional study, we found five patients with abnormal clot solubility test, among whom two patients abandoned the study, whereas three patients remained for a more precise study. All the patients were residents of Zaranj city, the capital of Nimruz Province. All these patients had undetectable activity of FXIII, which indicates a severe deficiency. Molecular analysis of patients showed mutation of Trp187Arg in all of them. Hematoma was the most common clinical presentation leading to diagnosis of FXIIID in these patients (100%). Epistaxis (67%), gum bleeding (33%), and hematuria (33%) were other recurrent clinical presentations of the patients. Three cases of death due to FXIIID were detected in the family of these patients. There was a high prevalence of FXIIID in Zaranj city with a population of 50 000, which was appropriately equal to the prevalence of the disorder in southeast of Iran, which seemed to have the highest global prevalence of FXIIID, and underlines that the same mutation (Trp187Arg) in both regions is same.
source
subjectEpistaxis -- Genetics ; Factor XIII -- Genetics ; Factor XIII Deficiency -- Genetics ; Genetic Diseases, Inborn -- Genetics ; Hematoma -- Genetics ; Hematuria -- Genetics;
version4
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutOvid.html$$EView_Wolters_Kluwer_Health,_Lippincott,_Williams_&_Wilkins_Copyright_Statement
search
creatorcontrib
0Hosseini, Soudabeh
1Dorgalaleh, Akbar
2Bamedi, Taregh
3Tavakol, Khanagha
4Tabibian, Shadi
5Naderi, Majid
6Alizadeh, Shaban
7Varmaghani, Bijan
8Shamsizadeh, Morteza
9Rahimizadeh, Aziz
10Ebrahimi, Sharif
titleFirst cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran
descriptionFactor XIII deficiency (FXIIID) is an extremely rare bleeding disorder with the highest global incidence in southeast of Iran. Southwestern Afghanistan (Nimruz Province) is located near the border with Iran in the vicinity of Sistan and Baluchestan Province in southeast Iran, and there seems to be a high prevalence of FXIIID in Nimruz. Thus, this cross-sectional study was designed to assess the prevalence of FXIIID, molecular basis as well as clinical manifestations of FXIIID in Southwestern Afghanistan. During the course of the study, all patients suspected of FXIIID were clinically examined and assessed by routine coagulation tests, including bleeding time, activated partial thromboplastin time, prothrombin time, as well as platelet count and clot solubility test. Patients with normal routine coagulation tests, but abnormal clot solubility test, underwent further investigations by FXIII activity, as well as molecular analysis for FXIII-A gene mutation (Trp187Arg) by PCR-restriction fragment length polymorphism that confirmed by sequencing. Patients with confirmed FXIIID deficiency were registered to receive prophylaxis treatment. All data including demographic information, clinical manifestations, as well as therapeutic response and type and duration of treatment, were recorded, and the data were analyzed by SPSS software. In this cross-sectional study, we found five patients with abnormal clot solubility test, among whom two patients abandoned the study, whereas three patients remained for a more precise study. All the patients were residents of Zaranj city, the capital of Nimruz Province. All these patients had undetectable activity of FXIII, which indicates a severe deficiency. Molecular analysis of patients showed mutation of Trp187Arg in all of them. Hematoma was the most common clinical presentation leading to diagnosis of FXIIID in these patients (100%). Epistaxis (67%), gum bleeding (33%), and hematuria (33%) were other recurrent clinical presentations of the patients. Three cases of death due to FXIIID were detected in the family of these patients. There was a high prevalence of FXIIID in Zaranj city with a population of 50 000, which was appropriately equal to the prevalence of the disorder in southeast of Iran, which seemed to have the highest global prevalence of FXIIID, and underlines that the same mutation (Trp187Arg) in both regions is same.
general
010.1097/MBC.0000000000000358
1Copyright © 2015 YEAR Wolters Kluwer Health, Inc. All rights reserved.
2Lippincott Williams & Wilkins - Journals
sourceidovid
recordidovid10.1097/MBC.0000000000000358
issn
00957-5235
109575235
rsrctypearticle
creationdate2015
addtitleBlood Coagulation & Fibrinolysis
searchscopeovid
scopeovid
lsr30VSR-Enriched:[subject, eissn, pqid]
sort
titleFirst cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran
authorHosseini, Soudabeh ; Dorgalaleh, Akbar ; Bamedi, Taregh ; Tavakol, Khanagha ; Tabibian, Shadi ; Naderi, Majid ; Alizadeh, Shaban ; Varmaghani, Bijan ; Shamsizadeh, Morteza ; Rahimizadeh, Aziz ; Ebrahimi, Sharif
creationdate20151200
facets
frbrgroupid6898317458262961192
frbrtype5
creationdate2015
collectionLippincott Williams & Wilkins Journals (Wolters Kluwer Health)
prefilterarticles
rsrctypearticles
creatorcontrib
0Hosseini, Soudabeh
1Dorgalaleh, Akbar
2Bamedi, Taregh
3Tavakol, Khanagha
4Tabibian, Shadi
5Naderi, Majid
6Alizadeh, Shaban
7Varmaghani, Bijan
8Shamsizadeh, Morteza
9Rahimizadeh, Aziz
10Ebrahimi, Sharif
jtitleBlood Coagulation & Fibrinolysis
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Hosseini
1Dorgalaleh
2Bamedi
3Tavakol
4Tabibian
5Naderi
6Alizadeh
7Varmaghani
8Shamsizadeh
9Rahimizadeh
10Ebrahimi
aufirst
0Soudabeh
1Akbar
2Taregh
3Khanagha
4Shadi
5Majid
6Shaban
7Bijan
8Morteza
9Aziz
10Sharif
au
0Hosseini, Soudabeh
1Dorgalaleh, Akbar
2Bamedi, Taregh
3Tavakol, Khanagha
4Tabibian, Shadi
5Naderi, Majid
6Alizadeh, Shaban
7Varmaghani, Bijan
8Shamsizadeh, Morteza
9Rahimizadeh, Aziz
10Ebrahimi, Sharif
atitleFirst cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran
jtitleBlood Coagulation & Fibrinolysis
risdate201512
volume26
issue8
spage908
epage911
pages908-911
issn0957-5235
formatjournal
genrearticle
ristypeJOUR
abstractFactor XIII deficiency (FXIIID) is an extremely rare bleeding disorder with the highest global incidence in southeast of Iran. Southwestern Afghanistan (Nimruz Province) is located near the border with Iran in the vicinity of Sistan and Baluchestan Province in southeast Iran, and there seems to be a high prevalence of FXIIID in Nimruz. Thus, this cross-sectional study was designed to assess the prevalence of FXIIID, molecular basis as well as clinical manifestations of FXIIID in Southwestern Afghanistan. During the course of the study, all patients suspected of FXIIID were clinically examined and assessed by routine coagulation tests, including bleeding time, activated partial thromboplastin time, prothrombin time, as well as platelet count and clot solubility test. Patients with normal routine coagulation tests, but abnormal clot solubility test, underwent further investigations by FXIII activity, as well as molecular analysis for FXIII-A gene mutation (Trp187Arg) by PCR-restriction fragment length polymorphism that confirmed by sequencing. Patients with confirmed FXIIID deficiency were registered to receive prophylaxis treatment. All data including demographic information, clinical manifestations, as well as therapeutic response and type and duration of treatment, were recorded, and the data were analyzed by SPSS software. In this cross-sectional study, we found five patients with abnormal clot solubility test, among whom two patients abandoned the study, whereas three patients remained for a more precise study. All the patients were residents of Zaranj city, the capital of Nimruz Province. All these patients had undetectable activity of FXIII, which indicates a severe deficiency. Molecular analysis of patients showed mutation of Trp187Arg in all of them. Hematoma was the most common clinical presentation leading to diagnosis of FXIIID in these patients (100%). Epistaxis (67%), gum bleeding (33%), and hematuria (33%) were other recurrent clinical presentations of the patients. Three cases of death due to FXIIID were detected in the family of these patients. There was a high prevalence of FXIIID in Zaranj city with a population of 50 000, which was appropriately equal to the prevalence of the disorder in southeast of Iran, which seemed to have the highest global prevalence of FXIIID, and underlines that the same mutation (Trp187Arg) in both regions is same.
pubCopyright © 2015 YEAR Wolters Kluwer Health, Inc. All rights reserved.
doi10.1097/MBC.0000000000000358
eissn14735733
date2015-12